skip to main content
Idioma:
Refinado por: Nome da Publicação: Bone Marrow Transplantation remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord

Nguyen, S ; Achour, A ; Souchet, L ; Vigouroux, S ; Chevallier, P ; Furst, S ; Sirvent, A ; Bay, J-O ; Socié, G ; Ceballos, P ; Huynh, A ; Cornillon, J ; Francois, S ; Legrand, F ; Yakoub-Agha, I ; Michel, G ; Maillard, N ; Margueritte, G ; Maury, S ; Uzunov, M ; Bulabois, C-E ; Michallet, M ; Clement, L ; Dauriac, C ; Bilger, K ; Lejeune, J ; Béziat, V ; Rocha, V ; Rio, B ; Chevret, S ; Vieillard, V

Bone marrow transplantation (Basingstoke), 2017-10, Vol.52 (10), p.1428-1435 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia
Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

Bazarbachi, Ali ; Labopin, Myriam ; Blaise, Didier ; Forcade, Edouard ; Socié, Gerard ; Berceanu, Ana ; Angelucci, Emanuele ; Bulabois, Claude Eric ; Kröger, Nicolaus ; Rambaldi, Alessandro ; Ceballos, Patrice ; Mielke, Stephan ; El Cheikh, Jean ; Yakoub-Agha, Ibrahim ; Savani, Bipin ; Spyridonidis, Alexandros ; Nagler, Arnon ; Mohty, Mohamad

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.622-634 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

Tessoulin, B ; Ceballos, P ; Chevallier, P ; Blaise, D ; Tournilhac, O ; Gauthier, J ; Maillard, N ; Tabrizi, R ; Choquet, S ; Carras, S ; Ifrah, N ; Guillerm, G ; Mohty, M ; Tilly, H ; Socie, G ; Cornillon, J ; Hermine, O ; Daguindau, É ; Bachy, E ; Girault, S ; Marchand, T ; Oberic, L ; Reman, O ; Leux, C ; Le Gouill, S

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1184-1190 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party

Bento, L ; Boumendil, A ; Finel, H ; Le Gouill, S ; Amorim, S ; Monjanel, H ; Bouabdallah, R ; Bay, J O ; Nicolas-Virelizier, E ; McQuaker, G ; Rossi, G ; Johnson, R ; Huynh, A ; Ceballos, P ; Rambaldi, A ; Bachy, E ; Malladi, R ; Orchard, K ; Pohlreich, D ; Tilly, H ; Bonifazi, F ; Poiré, X ; Guilhot, F ; Haenel, A ; Crawley, C ; Metzner, B ; Gribben, J ; Russell, N H ; Damaj, G ; Thomson, K ; Dreger, P ; Montoto, S

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1120-1125 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Stamatoullas, A ; Brice, P ; Gueye, M S ; Mareschal, S ; Chevallier, P ; Bouabdallah, R ; Nguyenquoc, S ; Francois, S ; Turlure, P ; Ceballos, P ; Monjanel, H ; Bourhis, J-H ; Guillerm, G ; Mohty, M ; Biron, P ; Cornillon, J ; Belhadj, K ; Bonmati, C ; Dilhuydy, M-S ; Huynh, A ; Bernard, M ; Chrétien, M-L ; Peffault de Latour, R ; Tilly, H

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.928-932 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
Material Type:
Artigo 		Adicionar ao Meu Espaço

Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT

Vincent, Laure ; Gras, Luuk ; Ceballos, Patrice ; Finke, Jürgen ; Passweg, Jakob ; Harel, Stéphanie ; Rosinol, Laura ; Minnema, Monique ; Teipel, Raphael ; van Doesum, Jaap ; Hänel, Mathias ; Lenain, Pascal ; Botella-Garcia, Carmen ; Koenecke, Christian ; Ducastelle, Sophie ; Sanz, Jaime ; Schroyens, Wilfried ; Zuckerman, Tsila ; Monaco, Federico ; Koster, Linda ; de Wreede, Liesbeth ; Hayden, Patrick J ; Schönland, Stefan ; Yakoub-Agha, Ibrahim ; Beksac, Meral

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.499-501 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation : a retrospective study of the EBMT Lymphoma Working Party
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation : a retrospective study of the EBMT Lymphoma Working Party
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation : a retrospective study of the EBMT Lymphoma Working Party

Bento, L ; Boumendil, A ; Finel, H ; Le Gouill, S ; Amorim, S ; Monjanel, H ; Bouabdallah, R ; Bay, J O ; Nicolas-Virelizier, E ; McQuaker, G ; Rossi, G ; Johnson, R ; Huynh, A ; Ceballos, P ; Rambaldi, A ; Bachy, E ; Malladi, R ; Orchard, K ; Pohlreich, D ; Tilly, H ; Bonifazi, F ; Poiré, X ; Guilhot, F ; Haenel, A ; Crawley, C ; Metzner, B ; Gribben, J ; Russell, N H ; Damaj, G ; Thomson, K ; Dreger, P ; Montoto, S

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1120 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation

Malladi, R ; Russell, N H ; Crawley, C ; Orchard, K ; Haenel, A ; Gribben, J ; Pohlreich, D ; Tilly, H ; Guilhot, F ; Thomson, K ; Bento, L ; Bay, J O ; Poiré, X ; Rambaldi, A ; Boumendil, A ; Damaj, G ; Bouabdallah, R ; Huynh, A ; Rossi, G ; Bonifazi, F ; Bachy, E ; Monjanel, H ; Finel, H ; Ceballos, P ; Nicolas-Virelizier, E ; Johnson, R ; Metzner, B ; Amorim, S ; Dreger, P ; Montoto, S ; Le Gouill, S ; McQuaker, G

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1120 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g m ) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g m ) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g m ) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients

QUITTET, P ; CEBALLOS, P ; ROUILLE, V ; DAURES, J. P ; KLEIN, B ; ROSSI, J. F ; LOPEZ, E ; LU, Z. Y ; LATRY, P ; BECHT, C ; LEGOUFFE, E ; FEGUEUX, N ; EXBRAYAT, C ; POUESSEL, D

Bone marrow transplantation (Basingstoke), 2006-08, Vol.38 (4), p.275-284 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Low doses of GM-CSF enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients
Low doses of GM-CSF enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low doses of GM-CSF enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients

Quittet, P ; Ceballos, P ; Lopez, E ; Lu, Z Y ; Latry, P ; Becht, C ; Legouffe, E ; Fegueux, N ; Exbrayat, C ; Pouessel, D ; Rouille, V ; Daures, J P ; Klein, B ; Rossi, J F

Bone marrow transplantation (Basingstoke), 2006-08, Vol.38 (4), p.275 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.